Muna Khan
Neurology with Special Qualifications in Child Neurology · Phoenix, AZNPI 1801009949
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.1% of the total across 135 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by UCB, Inc. at 25.6% of the total. Reporting peaked in 2022 at $811 and has fallen 79.3% since, to $168 in 2025.
Across 135 payments — averaging $22.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$777
- Livanova USA, Inc.$509
- Eisai Inc.$392
- SK Life Science, Inc.$255
- Greenwich Biosciences, Inc.$163
- Zogenix Inc.$146
- plus $796 from 15 others
What the payments were for
- Travel & lodging$1936%
- Food & beverage$2,82893%
- Education$171%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 48 | $777 |
| Livanova USA, Inc. | 5 | $509 |
| Eisai Inc. | 16 | $392 |
| SK Life Science, Inc. | 7 | $255 |
| Greenwich Biosciences, Inc. | 10 | $163 |
| Zogenix Inc. | 7 | $146 |
| Aquestive Therapeutics, Inc. | 9 | $135 |
| Neurelis, Inc. | 6 | $131 |
| Acadia Pharmaceuticals Inc | 4 | $114 |
| Sunovion Pharmaceuticals Inc. | 7 | $91 |
| Jazz Pharmaceuticals Inc. | 2 | $64 |
| Supernus Pharmaceuticals, Inc. | 4 | $62 |
| ITF Therapeutics LLC | 1 | $32 |
| AbbVie | 1 | $31 |
| AstraZeneca | 2 | $27 |
| Immedica Pharma US, Inc. | 1 | $21 |
| Catalyst Pharmaceuticals, Inc. | 1 | $21 |
| Metacel Pharmaceuticals LLC | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Molnlycke Health Care US, LLC | 1 | $16 |
| Aucta Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VNS Therapy$473
- Fycompa$214
How this compares
$3,038 in reported general payments places this provider in the 70th percentile of 49 neurology with special qualifications in child neurology providers in Arizona.
See all neurology with special qualifications in child neurology providers in Arizona →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BanzelRufinamide | 11 | $39,825 |
| Oxcarbazepine | 44 | $5,166 |
| Glycopyrrolate | 17 | $4,276 |
| Divalproex Sodium | 26 | $4,198 |
| Clobazam | 26 | $2,807 |
| Lacosamide | 22 | $2,739 |
| Baclofen | 44 | $1,219 |
| Levetiracetam | 33 | $836 |
| Topiramate | 37 | $709 |
| Levocarnitine | 11 | $583 |
| Lamotrigine | 37 | $499 |
| Clonazepam | 32 | $465 |
| Valproic AcidValproic Acid (As Sodium Salt) | 21 | $437 |
| Zonisamide | 17 | $404 |
| Tizanidine Hcl | 12 | $120 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Eisai Inc.Banzel | $392 | $39,82511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 49 neurology with special qualifications in child neurology providers in Arizona.
Other neurology with special qualifications in child neurology in Phoenix
- Angus WilfongPhoenix$348K
- Clara ChowPhoenix$35K
- Saunder BernesPhoenix$27K
- Randa JarrarPhoenix$25K
- Jeffrey BuchhalterPhoenix$19K
- Korwyn WilliamsPhoenix$13K
- Harlori BainsPhoenix$12K
- Tamara ZachPhoenix$10K
- Javier CardenasPhoenix$6K
- Vinodh NarayananPhoenix$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.